ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,930.85
1.09%
US Tech 100
20,836.00
1.31%
Dow Jones
42,840.26
1.18%
Brent Oil
72.72
0.00%
Bitcoin
97,574.22
-0.19%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Germany
  5. TG

  6. Johnson And Johnson (JNJ) Quote

Johnson And Johnson

Johnson And Johnson (JNJ)

Johnson and Johnson
Johnson and Johnson
138.52
0.06
(0.04%)
Closed December 21 4:00PM
Realtime Data

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
138.52
Bid
138.32
Ask
138.72
Volume
10,149
137.22 Day's Range 139.36
132.74 52 Week Range 153.98
Market Cap
333.504B
Previous Close
138.46
Open
138.52
Last Trade
5
@
138.84
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
8,575
Shares Outstanding
2,407,622,972
Dividend Yield
3.73%
PE Ratio
9.89
Earnings Per Share (EPS)
14.6
Revenue
85.16B
Net Profit
35.15B

About Johnson And Johnson

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.jnj.com
Headquarters
New Brunswick, New Jersey, USA
Founded
-
Johnson And Johnson is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker JNJ. The last closing price for Johnson And Johnson was 138.46 €. Over the last year, Johnson And Johnson shares have traded in a share price range of 132.74 € to 153.98 €.

Johnson And Johnson currently has 2,407,622,972 shares outstanding. The market capitalization of Johnson And Johnson is 333.36 € billion. Johnson And Johnson has a price to earnings ratio (PE ratio) of 9.89.

Ask ADVFN Intelligence (AI)

JNJ Latest News

More News

Johnson & Johnson to Participate in RBC Capital Markets' Health Care Conference

NEW BRUNSWICK, N.J., Feb. 23 /PRNewswire-FirstCall/ -- Johnson & Johnson will participate in the RBC Capital Markets' Health Care Conference on Tuesday, March 2, 2010, at the New York Palace...

February 23 2010
PR Newswire (US)

Cordis Corporation Announces Agreement With Boston Scientific To Resolve Certain Coronary Stent Patent Disputes

Cordis to Receive $1.725 Billion BRIDGEWATER, N.J., Feb. 1 /PRNewswire/ -- Cordis Corporation, a Johnson & Johnson company, announced today that it has reached an agreement with Boston Scientific...

February 01 2010
PR Newswire (US)

Johnson & Johnson Reports 2009 Fourth-Quarter and Full-Year Results:

2009 Fourth-Quarter Sales of $16.6 Billion increased 9.0%; EPS was $0.79 2009 Full-Year Sales of $61.9 Billion decreased 2.9%; Full-Year EPS was $4.40 Excluding Special Items, 2009 Fourth-Quarter...

January 26 2010
PR Newswire (US)

Johnson & Johnson to Host Analyst Meeting to Discuss Fourth-Quarter and Full-Year 2009 Financial Results

NEW BRUNSWICK, N.J., Jan. 19 /PRNewswire-FirstCall/ -- Johnson & Johnson will host an analyst meeting at 8:30 a.m. (Eastern Time) on Tuesday, January 26, 2010, to discuss fourth-quarter and...

January 19 2010
PR Newswire (US)

Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (ri

TITUSVILLE, N.J., Dec. 10 /PRNewswire/ -- Treatment with once-monthly INVEGA® SUSTENNA(TM) is not inferior to treatment with bi-weekly RISPERDAL® CONSTA®, according to new data from a...

December 10 2009
PR Newswire (US)

Longer Prescribed Replacement Intervals Leads to More Stretching of Frequent Replacement Contact Lenses

ORLANDO, Fla., Nov. 11 /PRNewswire-FirstCall/ -- Contact lenses prescribed for longer replacement intervals can lead to more extreme over wear (stretching) that could lead to undesirable...

November 11 2009
PR Newswire (US)

VisionCare Implantable Telescope Technology Presentations Featured at Upcoming American Academy of Ophthalmology and Ophthalmolo

Telescope Prosthesis for End-Stage Macular Degeneration Highlighted SARATOGA, Calif., Oct. 20 /PRNewswire/ -- VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic...

October 20 2009
PR Newswire (US)

New SIMPONI(TM) Data Show Long-Term Efficacy in Treatment of Rheumatoid Arthritis

Patients with Active Rheumatoid Arthritis Receiving SIMPONI Demonstrated Sustained Improvements in Signs and Symptoms Through One Year PHILADELPHIA, Oct. 19 /PRNewswire/ -- New long-term data...

October 19 2009
PR Newswire (US)

New SIMPONI(TM) Data Show Inhibition of Joint Damage in Patients With Rheumatoid Arthritis and Psoriatic Arthritis

Results from Radiographic Analyses Show Efficacy of SIMPONI in Inhibiting Joint Destruction in Two Rheumatic Conditions PHILADELPHIA, Oct. 19 /PRNewswire/ -- Phase 3 data reported for the first...

October 19 2009
PR Newswire (US)

Johnson & Johnson to Host Analyst Meeting to Discuss Third-Quarter Financial Results and Review Medical Devices & Diagnostics Bu

NEW BRUNSWICK, N.J., Oct. 6 /PRNewswire-FirstCall/ -- Johnson & Johnson will host an analyst meeting at 8:30 a.m. (Eastern Time) on Tuesday, Oct. 13, 2009, to discuss third-quarter financial...

October 06 2009
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.44-1.02886539011139.96140.84136.5214278138.80539584DE
4-9.52-6.43069440692148.04150.88136.5210067141.95687858DE
12-6.02-4.16493704165144.54153.97999136.528575145.33718389DE
262.782.04803300427135.74153.97999133.699998518144.66827219DE
52-4.08-2.86115007013142.6153.97999132.749185143.21514254DE
156-8.94-6.06266106063147.46178.26132.746028148.45557733DE
2607.745.91833613702130.78178.26104.127628139.82969399DE

JNJ - Frequently Asked Questions (FAQ)

What is the current Johnson And Johnson share price?
The current share price of Johnson And Johnson is 138.52 €
How many Johnson And Johnson shares are in issue?
Johnson And Johnson has 2,407,622,972 shares in issue
What is the market cap of Johnson And Johnson?
The market capitalisation of Johnson And Johnson is EUR 333.36B
What is the 1 year trading range for Johnson And Johnson share price?
Johnson And Johnson has traded in the range of 132.74 € to 153.98 € during the past year
What is the PE ratio of Johnson And Johnson?
The price to earnings ratio of Johnson And Johnson is 9.89
What is the cash to sales ratio of Johnson And Johnson?
The cash to sales ratio of Johnson And Johnson is 4.08
What is the reporting currency for Johnson And Johnson?
Johnson And Johnson reports financial results in USD
What is the latest annual turnover for Johnson And Johnson?
The latest annual turnover of Johnson And Johnson is USD 85.16B
What is the latest annual profit for Johnson And Johnson?
The latest annual profit of Johnson And Johnson is USD 35.15B
What is the registered address of Johnson And Johnson?
The registered address for Johnson And Johnson is ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK, NEW JERSEY, 08933
What is the Johnson And Johnson website address?
The website address for Johnson And Johnson is www.jnj.com
Which industry sector does Johnson And Johnson operate in?
Johnson And Johnson operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GX6TPI Composites Inc
2.258 €
(92.66%)
18.75k
LTIAptose Biosciences Inc
0.278 €
(68.48%)
430.65k
36GGBM Resources Limited
0.008 €
(60.00%)
102.8k
7ZGAskari Metals Ltd
0.0104 €
(48.57%)
155k
VOPInvestigator Resources Ltd
0.017 €
(47.83%)
23.1k
PHPNGalectin Therapeutics Inc
0.90 €
(-53.61%)
3.69k
AWY0Percheron Therapeutics Ltd
0.0025 €
(-44.44%)
658.15k
H5EHelma Eigenheimbau Ag
0.04 €
(-40.83%)
29.35k
7KOCullinan Metals Corp
0.0076 €
(-35.59%)
3.5k
W47Grid Battery Metals Inc
0.01 €
(-35.48%)
1,000
AXIAtos SE
0.0021 €
(0.00%)
474.93M
D7GNel ASA
0.253 €
(-0.16%)
4.33M
RQ0DWave Quantum Inc
6.38 €
(3.44%)
2.96M
R9BDeFi Technologies Inc
2.67 €
(10.56%)
2.3M
3CPXiaomi Corporation
3.886 €
(2.47%)
2.29M

Discussion

View Full Feed
dinogreeves dinogreeves 43 seconds ago
He is saying that, there was an article on Friday that Supermicro invested 20 million dollars in planting trees and vineyards, to help mitigate climate change and just maybe Charles likes drinking Wine. I believe LJ is trying to say there is no bullchit to that story, they have no reason to, it doe
SMCI
PennyStockTrader2 PennyStockTrader2 2 minutes ago
thanks. Im at around 500K shares, at these prices its worth it for me to maintain the position which is about 40% of my max. Its hard to predict what happens, but if we get another spike which is always possible, I will take most off the table as, like yourself, I have lost confidence in the company
DTGI
Investor082 Investor082 3 minutes ago
Doesn’t give anyone the reason to lie to shareholders. Lost over 60% value from that point on.

LP loves such bag holders!
NWBO
Evergreen Plateau Evergreen Plateau 4 minutes ago
Ggsm
Gonna load as much as possible at these levels
.ooo8 wow
Sideem Sideem 4 minutes ago
My break even price is $4.77. Just a buck and some change away.
BB
Evergreen Plateau Evergreen Plateau 5 minutes ago
Good day..
Not sure if you are still active..
Took a deep look at GGSM the other day..
Too much to list .
Check it out
Cheers
GGSM
GolfnutBoston GolfnutBoston 5 minutes ago
Rich, I'm not saying there's a company OneMind problem per se. 
FY2021 total revenue $935K
FY 2022 total revenue just under $1.5 million,
FY2023 on last years annual report stated just under $2 million in total revenue. 
So far this year 2024 from the 3 quarterly reports
AFFU
rouge Vaughn rouge Vaughn 5 minutes ago
nobody knows who you are I have made money here over 5 figures and will continue
go get dividend package you want a steady flow of income with little to no work. speak for yourself you do not speak for me or anyone else we will continue to make money here and load up while it's cheap as for
NSAV
JRoon71 JRoon71 6 minutes ago
Denisk, I got the impression that it was 180EU to Amarin, and the difference (to 239) is the allowable markup that pharmacies are allowed for their own costs and profit.

Maybe I am reading it wrong.
AMRN
manibiotech manibiotech 6 minutes ago
Well they didn't specify revenue to whom
NWBO
PennyStockTrader2 PennyStockTrader2 6 minutes ago
to your points ...

1) maybe maybe not, thats to be determined. A better way to look at it is to make sure you own lots of those cheap shares.
2) the notes come due every so often its just one lender thats it, they get a price and they get shares, and its a lot of shares as we'v
IPSI
sumbuysumsell sumbuysumsell 6 minutes ago
Related to provisional activity originating 23-11-2021?

This application claims the benefit of U.S. Provisional Patent Application No. 63/282,615, filed on Nov. 23, 2021, and U.S. Provisional Patent Application No. 63/393,573, filed on Jul. 29, 2022, the entire disclosures of wh
AVXL
MiamiGent MiamiGent 6 minutes ago
Trump betta hurry up and become President. I don't know how long Putin's patience can hold.

We know all this is being directed by US/NATO military


https://www.reuters.com/world/europe/russias-kazan-airport-temporarily-halts-operations-aviation-watchdog-says-2024
Monroe1 Monroe1 7 minutes ago
Thanks for this video. What a choir. I heard them once years ago on my way up to Alaska.
MiamiGent MiamiGent 8 minutes ago
Trump betta hurry up and become President. I don't know how long Putin's patience can hold.

We know all this is being directed by US/NATO military


https://www.reuters.com/world/europe/russias-kazan-airport-temporarily-halts-operations-aviation-watchdog-says-2024
doc2016 doc2016 8 minutes ago
i think remote use of quantum computers will be more generally available for science and the governments involvement in science. :gemini ai says:
"2.0 Experimental Advanced. Lacks access to real-time info and some Gemini features.
The US government can leverage quantum computing in nu
IONQ
dstock07734 dstock07734 8 minutes ago
It is fascinating even to picture which company could be the one that LP selected among many parties which have considerable interest in providing complementary technologies. For biotech, would a company show considerable interest in something without knowing it or without careful due diligence abou
NWBO
JRoon71 JRoon71 8 minutes ago
RMB, don't really know that. 

I get the impression that each region has their own overall budget that they have to stick to (not a per-drug limit). But I sort of doubt they would cut off scripts in any way if they exceed their budget.

At worse, they would re-negotiate w
AMRN
KVM KVM 10 minutes ago
If a quarter of what Veri said was true would be at least a $25 stock right now
VERI
Wolf-man jack Wolf-man jack 10 minutes ago
WQLF SAYS;

Geno Said; In response to the G-man

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165870330


Wolfie in Response to the G-man:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165868702
CVSI
rouge Vaughn rouge Vaughn 10 minutes ago
it's always the same creeps saying the same thing
based on what the fact that the price isn't always green, I dont even know what to call you people anymore
complaining like children cause you can't get your way. then the same group of people will flood the board when the price goes b
NSAV
Monroe1 Monroe1 11 minutes ago
They often do. Even empty crooked shells have value for a new owner. A new seed planted can bear good fruit too.
These are risky but sure can pay off nicely at times. Not bearish or bullish just here to play. As always ...tik tok.
Roll dem bones.
FCGD
FatedFish FatedFish 11 minutes ago
What announcement? Link? 
QS

Your Recent History

TG
JNJ
Johnson And Johnson
COIN
HSNBTC
Helper Search Token
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads